SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-20-095495
Filing Date
2020-08-14
Accepted
2020-08-14 16:02:51
Documents
50
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2020419-1_10q.htm 10-Q 550835
2 EXHIBIT 31.1 tm2020419d1_ex31-1.htm EX-31.1 10189
3 EXHIBIT 32.1 tm2020419d1_ex32-1.htm EX-32.1 5437
  Complete submission text file 0001104659-20-095495.txt   3092290

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT rgrx-20200630.xml EX-101.INS 615297
5 XBRL TAXONOMY EXTENSION SCHEMA rgrx-20200630.xsd EX-101.SCH 33852
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE rgrx-20200630_cal.xml EX-101.CAL 33471
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE rgrx-20200630_def.xml EX-101.DEF 75922
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE rgrx-20200630_lab.xml EX-101.LAB 246685
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rgrx-20200630_pre.xml EX-101.PRE 204212
Mailing Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD SUITE 470 ROCKVILLE MD 20850 301-208-9191
REGENERX BIOPHARMACEUTICALS INC (Filer) CIK: 0000707511 (see all company filings)

IRS No.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15070 | Film No.: 201104928
SIC: 2834 Pharmaceutical Preparations